Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
Sales | 1,217 | 742 | 660 | 67 | 4 |
Gross Profit | 1,217 | 742 | 660 | 67 | 4 |
Operating Expenses | 58,177 | 37,153 | 20,436 | 28,736 | 21,056 |
Operating Income | -56,960 | -36,411 | -19,776 | -28,669 | -21,052 |
Interest Expense | 422 | 272 | 303 | 323 | 285 |
Other Income | 1,900 | 1,110 | 353 | 1,149 | 1,578 |
Pre-tax Income | -55,482 | -35,573 | -19,726 | -27,843 | -19,759 |
Net Income Continuous | -55,482 | -35,573 | -19,726 | -27,843 | -19,759 |
Net Income | $-55,482 | $-35,573 | $-19,726 | $-27,843 | $-19,759 |
EPS Basic Total Ops | -0.99 | -0.69 | -0.51 | -0.86 | -0.68 |
EPS Basic Continuous Ops | -0.99 | -0.69 | -0.51 | -0.86 | -0.68 |
EPS Diluted Total Ops | -0.99 | -0.69 | -0.51 | -0.86 | -0.68 |
EPS Diluted Continuous Ops | -0.99 | -0.69 | -0.51 | -0.86 | -0.68 |
EBITDA(a) | $-54,990 | $-35,500 | $-18,174 | $-26,416 | $-19,163 |